e-Article
ENESTop 5-Year Update: Durability of Treatment-Free Remission Following Second-Line Nilotinib and Exploratory Analysis of Molecular Response Regain after Nilotinib Re-Initiation in Patients with Chronic Myeloid Leukemia
Document Type
Abstract
Author
Source
In Blood 5 November 2020 136 Supplement 1:29-30
Subject
Language
ISSN
0006-4971